Last reviewed: July 15, 2026
Last updated: July 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces significant metabolic changes, with clinical trials showing up to 22% body weight reduction over 68 weeks. Understanding how dosage escalation works and what to expect at each step empowers you to manage your weight loss journey with confidence. PlexusDx delivers compounded tirzepatide injections with transparent, flat-rate pricing—your dose may go up, but your cost won't.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Tirzepatide Dosing Works: The Titration Protocol
Tirzepatide therapy begins at a low starting dose and increases gradually over several weeks in what's called a titration schedule. This step-wise approach allows your body to adapt to the medication, reduces nausea and gastrointestinal side effects, and helps identify the dose level that delivers your optimal weight loss response. Most patients move through four dose levels: 2.5 mg, 5 mg, 10 mg, and 15 mg, advancing every 4 weeks if tolerated well.
The purpose of gradual titration is twofold: safety and efficacy. Your appetite suppression deepens as doses increase, and your metabolic rate improvements compound over time. Skipping doses or advancing too quickly often leads to intolerable nausea, while moving slowly allows you to find your therapeutic sweet spot—the dose that suppresses hunger without causing distressing side effects.
Starting Dose and Weekly Injections: What to Expect
Your first dose of tirzepatide is 2.5 mg given as a subcutaneous injection once weekly, typically in the thigh, abdomen, or upper arm. This starter dose is designed to be gentle; most people experience mild appetite reduction and stable blood sugar within the first 2–3 injections. Some patients report no side effects at this level, while others notice subtle changes in food preferences or fullness after smaller meals.
Weekly injection timing remains consistent throughout your entire tirzepatide course. You'll inject the same day each week—many patients choose Monday or Sunday for consistency. Even when your dose advances to 5 mg, 10 mg, or 15 mg, you're still administering one injection per week; the vial concentration changes, not the injection frequency. PlexusDx ships your compounded tirzepatide in pre-filled pens or multi-dose vials with easy-to-follow instructions.
Dose Escalation Schedule: When and Why Your Doctor Increases Your Dose
After four weeks on your starting dose, your PlexusDx healthcare provider reviews your tolerability and weight loss progress. If you're managing side effects well and hunger is still present, the dose advances to 5 mg for the next four weeks. This pattern continues: week 5–8 at 5 mg, week 9–12 at 10 mg, and week 13 onward at 15 mg (the maintenance dose) unless your provider tailors a different trajectory based on your response.
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Flat Monthly Pricing: Your Cost Stays the Same Across All Dose Levels
PlexusDx charges one flat monthly rate for compounded tirzepatide injection regardless of whether you're at 2.5 mg, 5 mg, 10 mg, or 15 mg. Compounded Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan across all three commitment tiers, eliminating the anxiety of 'dose ladder' pricing used by other providers. This transparent model means your out-of-pocket cost never increases as your clinical needs evolve and your dose advances.
Because PlexusDx operates with licensed 503A compounding pharmacies, pricing reflects the clinical management and medication formulation—not dose-based markup. HSA and FSA accounts cover tirzepatide injections, making your therapy accessible regardless of insurance status. This flat-rate approach aligns your financial interests with your clinical progress: you can confidently pursue the dose your body needs without worrying about mounting costs.
Managing Side Effects During Dose Increases
Nausea is the most common side effect during early titration and often peaks a few days after injection, then gradually improves over the week. Eating smaller, lower-fat meals; staying hydrated; and taking ginger or anti-nausea supplements can ease discomfort. If nausea is severe, your PlexusDx provider may extend your time at the current dose before advancing, giving your body more weeks to adapt.
Constipation and fatigue are also frequently reported during the first 4–8 weeks. Increasing fiber intake, drinking more water, and adding gentle exercise supports bowel regularity. Fatigue typically reflects your body's metabolic shift and usually resolves within 2–3 weeks. Your PlexusDx team monitors these effects at each follow-up and adjusts your titration timeline if needed to ensure your experience is safe and sustainable.
Genetic Testing and Your Personalized Dose Response
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Understanding your FTO rs9939609 and MC4R rs17782313 variants also clarifies your baseline hunger drive and metabolic rate, helping your provider set realistic weight loss targets and explain why your dose trajectory may differ from someone else's. This genetic insight removes guesswork from your treatment plan and empowers you to advocate for the dose and timeline that matches your biological reality.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I have to reach the 15 mg maintenance dose, or can I stay on a lower dose?
No, you're never required to advance beyond a dose that works for you. Many patients achieve their weight loss goals and sustained appetite control at 5 mg or 10 mg and choose to remain there indefinitely. Your PlexusDx provider tailors your endpoint based on your tolerability, response, and clinical goals—not a one-size-fits-all protocol.
How much weight loss can I expect at each dose level?
No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Will my price increase if I need a higher dose?
No. PlexusDx charges a flat monthly rate for Compounded Tirzepatide Injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, regardless of dose. Your dose may increase, but your price won't, making it easy to pursue the treatment level your body needs without financial surprise.
What happens if I can't tolerate a dose increase?
Your PlexusDx provider can pause your titration, extend your time at the current dose, or reduce back to a previous dose if side effects become unmanageable. Tirzepatide is flexible—your treatment plan adapts to your tolerance, not the other way around. Most side effects resolve within 2–3 weeks with patience and lifestyle adjustments.
How does the Precision Peptide Genetic Test help with dosing?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss: How Old Do You Have to Be to Take Mounjaro?
How Close Is Mounjaro to Being Approved for Weight Loss?